Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

aTYR PHARMA (ATYR) Return on Assets (2019 - 2025)

aTYR PHARMA (ATYR) has disclosed Return on Assets for 7 consecutive years, with 0.78% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Assets fell 6.0% year-over-year to 0.78%, compared with a TTM value of 0.78% through Dec 2025, down 6.0%, and an annual FY2025 reading of 0.82%, down 19.0% over the prior year.
  • Return on Assets was 0.78% for Q4 2025 at aTYR PHARMA, down from 0.76% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.28% in Q4 2021 and bottomed at 0.78% in Q4 2025.
  • Average Return on Assets over 5 years is 0.52%, with a median of 0.5% recorded in 2022.
  • The sharpest move saw Return on Assets rose 18bps in 2022, then plummeted -33bps in 2024.
  • Year by year, Return on Assets stood at 0.28% in 2021, then crashed by -70bps to 0.48% in 2022, then rose by 8bps to 0.45% in 2023, then plummeted by -61bps to 0.72% in 2024, then fell by -8bps to 0.78% in 2025.
  • Business Quant data shows Return on Assets for ATYR at 0.78% in Q4 2025, 0.76% in Q3 2025, and 0.7% in Q2 2025.